GASTROINTESTINAL STROMAL TUMOR (GIST)
Clinical trials for GASTROINTESTINAL STROMAL TUMOR (GIST) explained in plain language.
Never miss a new study
Get alerted when new GASTROINTESTINAL STROMAL TUMOR (GIST) trials appear
Sign up with your email to follow new studies for GASTROINTESTINAL STROMAL TUMOR (GIST), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
First patients to try new pill for Tough-to-Treat stomach tumors
Disease control Recruiting nowThis is the first-ever study in people for an experimental pill called IDRX-42. It aims to find a safe dose and see if it can help control advanced gastrointestinal stromal tumors (GIST) that have spread or cannot be removed by surgery. The study will enroll adults whose cancer h…
Matched conditions: GASTROINTESTINAL STROMAL TUMOR (GIST)
Phase: PHASE1 • Sponsor: IDRx Inc. - A GSK Company • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New hope for tough stomach tumors: experimental drug combo enters human testing
Disease control Recruiting nowThis early-stage trial is testing the safety and initial effectiveness of a new oral drug, ziftomenib, when given alongside the standard drug imatinib. It is for adults with advanced gastrointestinal stromal tumors (GIST) whose cancer has continued to grow despite treatment with …
Matched conditions: GASTROINTESTINAL STROMAL TUMOR (GIST)
Phase: PHASE1 • Sponsor: Kura Oncology, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New hope for Tough-to-Treat gut cancers
Disease control Recruiting nowThis study is testing whether a new drug called DCC-3009 is safe and effective for treating advanced gastrointestinal stromal tumors (GIST), a type of cancer in the digestive system. It will enroll about 120 adults whose cancer has continued to grow despite standard treatments. T…
Matched conditions: GASTROINTESTINAL STROMAL TUMOR (GIST)
Phase: PHASE1, PHASE2 • Sponsor: Deciphera Pharmaceuticals, LLC • Aim: Disease control
Last updated Mar 04, 2026 15:29 UTC
-
Scientists track rare stomach tumors for a decade to find new treatments
Knowledge-focused Recruiting nowThis study aims to better understand gastrointestinal stromal tumors (GIST) by following patients for up to 10 years and collecting tumor tissue during any needed surgeries. Researchers will monitor 400 participants, including children as young as 6, to study the tumors in the la…
Matched conditions: GASTROINTESTINAL STROMAL TUMOR (GIST)
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:42 UTC
-
Stanford scientists search for cancer clues in patient samples
Knowledge-focused Recruiting nowThis study aims to understand how genes and proteins contribute to the development of stomach and esophageal cancers. Researchers will analyze tissue samples from biopsies and blood samples from patients with these cancers or those at high inherited risk. The goal is to gather kn…
Matched conditions: GASTROINTESTINAL STROMAL TUMOR (GIST)
Sponsor: Stanford University • Aim: Knowledge-focused
Last updated Apr 02, 2026 14:57 UTC